Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02721446 · ClinicalTrials.gov registry record · NA

MINDSPACE Strategy for Risk Optimization

A NA study of Stroke, sponsored by Indiana Institute for Medical Research.

Completed
Registry status
NA
Development phase
641
Enrollment target
1
Study location

NCT02721446: Completed NA study of Stroke, sponsored by Indiana Institute for Medical Research.

NCT02721446 is a NA study of Stroke that has completed, run by Indiana Institute for Medical Research. The registered enrollment target is 641 participants, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02721446, a NA study of Stroke, has completed, sponsored by Indiana Institute for Medical Research.

COMPLETED
Registry status
NA
Development phase
641 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to find out which types of written stroke messages may help high risk stroke patients take action to improve their health.

Conditions Studied

Interventions

  • BEHAVIORAL Incentive
  • BEHAVIORAL Standard
  • BEHAVIORAL Salience
  • BEHAVIORAL Incentive + Salience

Study Locations (1)

Indiana

  • Richard L. Roudebush VA Medical Center - Indianapolis

Trial Details

FieldValue
Enrollment Target 641 participants
Start Date 2016-06
Est. Completion 2018-08
Phase NA

What the Registry Record Tells You About NCT02721446

The ClinicalTrials.gov registry entry for NCT02721446 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 641 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (95% lower). The listed sponsor is Indiana Institute for Medical Research, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 4 interventions - of which Incentive is the first listed.

NCT02721446 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT02721446 about?

NCT02721446 is a clinical study titled "MINDSPACE Strategy for Risk Optimization". The purpose of this study is to find out which types of written stroke messages may help high risk stroke patients take action to improve their health.

What is the current status of trial NCT02721446?

This trial is currently completed. It is a NA study. The enrollment target is 641 participants. The study started on 2016-06. Estimated completion is 2018-08.

What conditions does trial NCT02721446 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT02721446?

The interventions under investigation include: Incentive (BEHAVIORAL), Standard (BEHAVIORAL), Salience (BEHAVIORAL), Incentive + Salience (BEHAVIORAL).

Who is sponsoring clinical trial NCT02721446?

This trial is sponsored by Indiana Institute for Medical Research, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02721446 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.